[go: up one dir, main page]

IT8148332A0 - Procedimento per la produzione di un principio attivo fibrinolitico vasale prodotto enzimatico specifico angiochinasi cosi' ottenuto e sue applicazioni farmaceutiche - Google Patents

Procedimento per la produzione di un principio attivo fibrinolitico vasale prodotto enzimatico specifico angiochinasi cosi' ottenuto e sue applicazioni farmaceutiche

Info

Publication number
IT8148332A0
IT8148332A0 IT8148332A IT4833281A IT8148332A0 IT 8148332 A0 IT8148332 A0 IT 8148332A0 IT 8148332 A IT8148332 A IT 8148332A IT 4833281 A IT4833281 A IT 4833281A IT 8148332 A0 IT8148332 A0 IT 8148332A0
Authority
IT
Italy
Prior art keywords
angiokinase
procedure
production
active ingredient
pharmaceutical applications
Prior art date
Application number
IT8148332A
Other languages
English (en)
Other versions
IT8148332A1 (it
IT1170913B (it
Inventor
Comi Gaetano
Pandolfi Maurizio
Original Assignee
Manetti & Roberts Italo Brit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Manetti & Roberts Italo Brit filed Critical Manetti & Roberts Italo Brit
Publication of IT8148332A0 publication Critical patent/IT8148332A0/it
Priority to IT48332/81A priority Critical patent/IT1170913B/it
Priority to NZ200254A priority patent/NZ200254A/xx
Priority to AU82375/82A priority patent/AU548758B2/en
Priority to IL65448A priority patent/IL65448A/xx
Priority to US06/366,276 priority patent/US4471053A/en
Priority to PT74743A priority patent/PT74743B/pt
Priority to EP82830100A priority patent/EP0064036B1/en
Priority to NO821287A priority patent/NO821287L/no
Priority to DE8282830100T priority patent/DE3265559D1/de
Priority to AT82830100T priority patent/ATE15071T1/de
Priority to ZA822703A priority patent/ZA822703B/xx
Priority to DK180682A priority patent/DK180682A/da
Priority to IE952/82A priority patent/IE53107B1/en
Priority to CA000401425A priority patent/CA1184138A/en
Priority to ES511604A priority patent/ES8501797A1/es
Priority to JP57068538A priority patent/JPS57181019A/ja
Publication of IT8148332A1 publication Critical patent/IT8148332A1/it
Priority to US06/605,873 priority patent/US4532129A/en
Application granted granted Critical
Publication of IT1170913B publication Critical patent/IT1170913B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6456Plasminogen activators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
IT48332/81A 1981-04-23 1981-04-23 Procedimento per la produzione di un principio attivo fibrinolitico vasale prodotto enzimatico specifico angiochinasi cosi' ottenuto e sue applicazioni farmaceutiche IT1170913B (it)

Priority Applications (17)

Application Number Priority Date Filing Date Title
IT48332/81A IT1170913B (it) 1981-04-23 1981-04-23 Procedimento per la produzione di un principio attivo fibrinolitico vasale prodotto enzimatico specifico angiochinasi cosi' ottenuto e sue applicazioni farmaceutiche
NZ200254A NZ200254A (en) 1981-04-23 1982-04-06 Production of'angiokinase'and pharmaceutical compositions
AU82375/82A AU548758B2 (en) 1981-04-23 1982-04-06 Angiokinase, vasal fibrinolytic active principle
IL65448A IL65448A (en) 1981-04-23 1982-04-06 Procedure for producing a vasal fibrinolytic active principle and the enzymatic product so prepared
US06/366,276 US4471053A (en) 1981-04-23 1982-04-07 Process for producing a vasal fibrinolytic active principle and the enzymatic product so prepared
PT74743A PT74743B (en) 1981-04-23 1982-04-13 Procedure for producing a vasal fibrinolytic active principle plus the enzymatic product so prepared
DE8282830100T DE3265559D1 (en) 1981-04-23 1982-04-21 Procedure for producing a vasal fibrinolytic active principle and the enzymatic product so prepared
NO821287A NO821287L (no) 1981-04-23 1982-04-21 Fremgangsmaate for fremstilling av et enzym (angiokinase)
EP82830100A EP0064036B1 (en) 1981-04-23 1982-04-21 Procedure for producing a vasal fibrinolytic active principle and the enzymatic product so prepared
AT82830100T ATE15071T1 (de) 1981-04-23 1982-04-21 Verfahren zur herstellung eines aus blutbahnen gewonnenen aktiven fibrinolytischen prinzips sowie das so hergestellte enzym.
ZA822703A ZA822703B (en) 1981-04-23 1982-04-21 Procedure for producing a vasal fibrinolytic active principle plus the enzymatic products so prepared
CA000401425A CA1184138A (en) 1981-04-23 1982-04-22 Process for producing a vasal fibrinolytic active principle, and the enzymatic product so prepared
IE952/82A IE53107B1 (en) 1981-04-23 1982-04-22 Process for producing a vasal fibrinolytic active principle and the enzymatic product so prepared
DK180682A DK180682A (da) 1981-04-23 1982-04-22 Fremgangsmaade til fremstilling af et fibrinolytisk aktivt kar-princip og herved vundet enzymatisk produkt
ES511604A ES8501797A1 (es) 1981-04-23 1982-04-22 "un procedimiento para la obtencion de un principio activo fibrinolitico vasal o vascular, quimicamente denominable "enzima angioquinasa"".
JP57068538A JPS57181019A (en) 1981-04-23 1982-04-23 Manufacture of vascular fibrinolytic substance
US06/605,873 US4532129A (en) 1981-04-23 1984-05-01 Composition containing and method of using a fibrinolytic active principle

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48332/81A IT1170913B (it) 1981-04-23 1981-04-23 Procedimento per la produzione di un principio attivo fibrinolitico vasale prodotto enzimatico specifico angiochinasi cosi' ottenuto e sue applicazioni farmaceutiche

Publications (3)

Publication Number Publication Date
IT8148332A0 true IT8148332A0 (it) 1981-04-23
IT8148332A1 IT8148332A1 (it) 1982-10-23
IT1170913B IT1170913B (it) 1987-06-03

Family

ID=11265948

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48332/81A IT1170913B (it) 1981-04-23 1981-04-23 Procedimento per la produzione di un principio attivo fibrinolitico vasale prodotto enzimatico specifico angiochinasi cosi' ottenuto e sue applicazioni farmaceutiche

Country Status (16)

Country Link
US (2) US4471053A (it)
EP (1) EP0064036B1 (it)
JP (1) JPS57181019A (it)
AT (1) ATE15071T1 (it)
AU (1) AU548758B2 (it)
CA (1) CA1184138A (it)
DE (1) DE3265559D1 (it)
DK (1) DK180682A (it)
ES (1) ES8501797A1 (it)
IE (1) IE53107B1 (it)
IL (1) IL65448A (it)
IT (1) IT1170913B (it)
NO (1) NO821287L (it)
NZ (1) NZ200254A (it)
PT (1) PT74743B (it)
ZA (1) ZA822703B (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA831399B (en) * 1982-03-05 1984-02-29 Health Lab Service Board New fibrinolytic enzymes and methods for their production and pharmaceutical compositions containing them
JPS58189122A (ja) * 1982-04-30 1983-11-04 Kaken Pharmaceut Co Ltd 高脂血症予防治療剤
JPS61112018A (ja) * 1984-11-06 1986-05-30 Mitsubishi Chem Ind Ltd 線溶増強剤
US5165938A (en) * 1984-11-29 1992-11-24 Regents Of The University Of Minnesota Wound healing agents derived from platelets
US5275812A (en) * 1985-06-07 1994-01-04 The General Hospital Corporation Method of treatment for myocardial infarction
US5032608A (en) * 1986-09-10 1991-07-16 Dudrick Stanley J Method and substrate composition for treating atherosclerosis
US5248688A (en) * 1986-09-10 1993-09-28 Dudrick Medical Research Fund I, Ltd. Method and substrate composition for treating atherosclerosis
HU209955B (en) * 1987-07-01 1994-12-28 Genentech Inc Process for producing pharmaceutical compositions containing tissue- -plasminogen-activator of poor solubility for inhibiting production and regeneration of deformities
US5215908A (en) * 1989-06-13 1993-06-01 Genencor International, Inc. Process for recovery and purification of chymosin
US5449679A (en) * 1994-07-29 1995-09-12 Leonard; Robert J. Process and products for reducing biological fluid levels of a lipid soluble waste
US7745106B2 (en) * 1997-06-24 2010-06-29 Cascade Medical Enterprises, Llc Methods and devices for separating liquid components
US20080199513A1 (en) * 1997-06-24 2008-08-21 Cascade Medical Enterprises, Llc Systems and methods for preparing autologous fibrin glue
US6979307B2 (en) * 1997-06-24 2005-12-27 Cascade Medical Enterprises Llc Systems and methods for preparing autologous fibrin glue
WO1999066797A1 (en) 1998-06-22 1999-12-29 Worden Charles E Enriched platelet wound healant
WO2006102488A1 (en) * 2005-03-22 2006-09-28 Cascade Medical Enterprises, Llc Systems and methods of producing membranes
DE102015010436B4 (de) * 2015-08-14 2019-01-24 Airbus Defence and Space GmbH Wabenkern für dimensionsstabile Sandwichbauteile, dessen Verwendung, Sandwichplatte mit diesem Wabenkern und Verfahren zur Herstellung des Wabenkerns

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998847A (en) * 1972-10-25 1976-12-21 Schering Aktiengesellschaft 9,10-secoestrane derivatives and their production
US3998947A (en) * 1973-11-30 1976-12-21 Pierre Fabre S.A. Process for obtaining a plasminogen activator
US4245051A (en) * 1978-03-30 1981-01-13 Rockefeller University Human serum plasminogen activator
NZ191320A (en) * 1978-09-07 1982-09-14 Beecham Group Ltd In vivo fibrinolytic enzyme having active site blocked by hydrolytically removable group pharmaceutical compositions
US4374830A (en) * 1979-10-04 1983-02-22 Research Corp. Platelet aggregating material from equine arterial tissue
US4381346A (en) * 1979-11-13 1983-04-26 Huasin Syed S Isolation of plasminogen activators useful as therapeutic and diagnostic agents
US4390630A (en) * 1980-10-28 1983-06-28 The Regents Of The University Of California Hementin--a fibrinolytic agent

Also Published As

Publication number Publication date
US4471053A (en) 1984-09-11
IE53107B1 (en) 1988-06-22
IL65448A (en) 1985-07-31
CA1184138A (en) 1985-03-19
NZ200254A (en) 1985-07-12
IE820952L (en) 1982-10-23
ES511604A0 (es) 1984-12-01
DK180682A (da) 1982-10-24
ES8501797A1 (es) 1984-12-01
EP0064036B1 (en) 1985-08-21
US4532129A (en) 1985-07-30
IL65448A0 (en) 1982-07-30
PT74743B (en) 1983-11-09
DE3265559D1 (en) 1985-09-26
ZA822703B (en) 1983-03-30
PT74743A (en) 1982-05-01
EP0064036A1 (en) 1982-11-03
IT8148332A1 (it) 1982-10-23
AU8237582A (en) 1982-10-28
ATE15071T1 (de) 1985-09-15
IT1170913B (it) 1987-06-03
AU548758B2 (en) 1986-01-02
JPS57181019A (en) 1982-11-08
NO821287L (no) 1982-10-25

Similar Documents

Publication Publication Date Title
IT8148332A0 (it) Procedimento per la produzione di un principio attivo fibrinolitico vasale prodotto enzimatico specifico angiochinasi cosi' ottenuto e sue applicazioni farmaceutiche
NO851949L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotetralinderivater.
EG15926A (en) 4-phenylurazol derivatives and their production,and herbicides containing the same as an active ingredient
IT8125424A0 (it) Procedimento per la produzione di alfa -galattosidasi e impieghi dell'enzima cosi' ottenuto.
FI872379A7 (fi) Menetelmä farmakologisesti vaikuttavien 1,5-diaryyli-3-(w-substituoitu-alempi-alkyyli)-pyratsolien valmistamiseksi
IT8519873A0 (it) Procedimento di solubilizzazione di principi attivi e composizioni farmaceutiche cosi' ottenute.
FR2601259B1 (fr) Nouvelles compositions tensio-actives a base d'esters phosphoriques leur procede de preparation et leur application a la formulation de matieres actives.
NO162238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater.
ZA856905B (en) Expectorant
IT8020213A0 (it) Procedimento per la preparazione di copolimeri di polisaccaridi supportanti attivita' enzimatica, e copolimeri cosi' ottenuti.
USD274846S (en) Pharmaceutical tablet
FI823336A7 (fi) Menetelmä farmaseuttisesti aktiivisten bentsamidijohdannaisten valmistamiseksi.
HUT77375A (hu) Enterokinetikus hatású benzamidszármazékok, az ezeket tartalmazó gyógyszerkészítmények és eljárás a vegyületek előállítására
FI853648A7 (fi) Menetelmä farmaseuttisesti aktiivisten 4,5-dihydro-4-okso-2-/ (2-trans-fenyylisyklopropyyli)amino/ -3-furaanikarboksyylihappojen ja niiden johdannaisten valmistamiseksi.
IT1225474B (it) Procedimento per la preparazione di compresse solubili e/o divisibili e compresse cosi' ottenute.
IT8420479A0 (it) Procedimento per la fabbricazione di zeolite a e prodotti cosi'ottenuti.
HRP920575B1 (en) Solid oral administration forms containing ifosfamide as an active agent and a process for the production of the same
USD275615S (en) Pharmaceutical tablet
FI853343A7 (fi) Menetelmä farmaseuttisesti aktiivisten fenyyli-asetonitriilijohdannaisten valmistamiseksi.
IT1182715B (it) Procedimento per la produzione di un detergente e detergente cosi' ottenuto
IT9021905A0 (it) Procedimento per la produzione di manufatti fosforescenti e manufatti cosi' ottenuti
PT69235A (fr) Procede de preparation de nouvelles compositions pharmaceutiques a base d'enzyme bacterien
IT1207561B (it) Procedimento per la preparazione di un brodo di fermentazione per laproduzione di coenzima b 12 ed altri corrinoidi.
PT71883B (fr) Procede de preparation de compositions pharmaceutiques a base d'extraits aqueux de marcs des raisins rouges
IT8423453A0 (it) Procedimento per la produzione di un supporto espositore e prodotto cosi' ottenuto.